Clinical features of Parkinson’s disease patients are associated with therapeutic misconception and willingness to participate in clinical trials

BACKGROUND: Clinical trials (CTs) are the “gold standard” to ensure the development of new effective treatments in medicine. A study was conducted to assess knowledge of, and attitudes toward, clinical trials among patients with Parkinson’s disease (PD), along with factors that motivate them to part...

Descripción completa

Detalles Bibliográficos
Autores principales: Reijula, Emmi, Pietilä, Anna-Maija, Halkoaho, Arja, Selander, Tuomas, Martikainen, Kirsti, Kälviäinen, Reetta, Keränen, Tapani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622447/
https://www.ncbi.nlm.nih.gov/pubmed/28962634
http://dx.doi.org/10.1186/s13063-017-2174-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622447/
https://www.ncbi.nlm.nih.gov/pubmed/28962634
http://dx.doi.org/10.1186/s13063-017-2174-2

Ejemplares similares